Business
AxisBiotix Acne study reports positive data
AxisBiotix Acne study reports positive data.
About this update from Skinbiotherapeutics Plc
[{"type":"text","content":"\n\n\n \nSkinBioTherapeutics plc\n(\"SkinBioTherapeutics\" or \"the Company\")\n \n \nAxisBiotix Acne food supplement consumer study reports positive data \n\n· Very positive feedback from participants with a range of acne skin conditions\n· Improvement observed in spot appearance (84%) and pain caused by spots (77%)\n· 93% of participants completed exit study of which 89% reported they would continue using AxisBiotix supplement post-study\n· Determining end formulation for final consumer product is the next step in the commercialisation strategy\n \n18 June 2024 - SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that AxisBiotix Limited (\"AxisBiotix\"), a wholly owned subsidiary of the Company, has finalised the analysis of the data from its AxisBiotix Acne food supplement consumer study. Participant feedback was highly positive.\nThe 8-week consumer volunteer study of the food supplement blend, AxisBiotix Acne, commenced in January 2024. The study, which enrolled 98 people, followed the same methodology as the AxisBiotix-Ps study. The supplement containing the lead formulation was supplied to participants in powder-form. Participants were then asked to record scores against specific criteria on an app. The scoring criteria included severity of acne, level of pain, attitude to appearance and levels of confidence.\nStudy results\nThe participants provided feedback weekly via a bespoke app (85 participants reported every week - an 87% completion rate), as well as via an exit survey, which produced the following results:\n· 84% reported that the appearance of their spots had improved;\n· 77% reported that the pain caused by their spots had eased;\n· 62% reported that the anxiety they felt due to their spots had improved;\n· 58% reported that the impact their spots had on their social life had improved.\nOf the 91 participants that completed the exit survey (93% of participants), 89% reported that they would continue using the supplement and recommend it to others.\nAs part of the exit interviews, participants were also asked to comment on their experience using AxisBiotix. Statements included:\n\"My skin has greatly improved. [My] spots have reduced...